BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $48,480,000 | -21.2% | 5,955,762 | -21.9% | 4.80% | -38.3% |
| Q4 2018 | $61,512,000 | +1.0% | 7,622,256 | -4.5% | 7.78% | -18.0% |
| Q3 2018 | $60,874,000 | +42.1% | 7,978,275 | +6.7% | 9.49% | +59.7% |
| Q2 2018 | $42,851,000 | -99.9% | 7,478,275 | 0.0% | 5.94% | +12.1% |
| Q1 2018 | $35,671,000,000 | +152784.5% | 7,478,275 | +57.4% | 5.30% | +33.1% |
| Q4 2017 | $23,332,000 | +171.9% | 4,751,883 | +190.2% | 3.98% | +138.5% |
| Q3 2017 | $8,580,000 | +10.7% | 1,637,332 | +33.7% | 1.67% | +4.8% |
| Q4 2016 | $7,754,000 | +142.5% | 1,225,000 | +69.0% | 1.59% | +95.5% |
| Q3 2016 | $3,197,000 | – | 725,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |